Paid Clinical Trials Virginia Beach
Discover 356 paid clinical trials in Virginia Beach, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Dipraglurant with LevodopaDipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor:
Addex Pharma S.A.
Location:
Code:
NCT04857359
Conditions
Parkinson Disease
Dyskinesia, Drug-Induced
Dyskinesias
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Dipraglurant
Placebo
ADSTILADRINADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Sponsor:
Ferring Pharmaceuticals
Location:
Code:
NCT06026332
Conditions
Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ADSTILADRIN
Cerebral Aneurysms@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms
Sponsor:
University Hospital, Geneva
Location:
Code:
NCT05526352
Conditions
Intracranial Aneurysm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
XEN1101A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Sponsor:
Xenon Pharmaceuticals Inc.
Location:
Code:
NCT05667142
Conditions
Primary Generalized Tonic-Clonic Seizures
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
XEN1101
Placebo
Observational StudyMaturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Sponsor:
Sonavex, Inc.
Location:
Code:
NCT06190717
Conditions
Diabetes
End Stage Renal Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
EchoMark/EchoSure
Standard of Care
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Navtemadlin & RuxolitinibStudy of Navtemadlin Add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Sponsor:
Kartos Therapeutics, Inc.
Location:
Code:
NCT06479135
Conditions
Myelofibrosis
Post-PV MF
Post-ET Myelofibrosis
Primary Myelofibrosis
MF
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Navtemadlin
Navtemadlin placebo
Ruxolitinib
Cretostimogene GrenadenorepvecPhase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Sponsor:
CG Oncology, Inc.
Location:
Code:
NCT06567743
Conditions
High-Risk Non-Muscle-Invasive Bladder Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cretostimogene Grenadenorepvec
FibroNovaTreatment of Fibromyalgia With the FibroNova Neuromodulation Device
Sponsor:
Theranica
Location:
Code:
NCT06271746
Conditions
Fibromyalgia
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
FibroNova (Active mode)
FibroNova (Sham mode)
MCM5 Elisa TestA Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Sponsor:
Arquer Diagnostics Ltd
Location:
Code:
NCT05508568
Conditions
Bladder Cancer
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
ADXBLADDER
Observational StudyTotal Shoulder Arthroplasty Multi-Center Registry
Sponsor:
Arthrex, Inc.
Location:
Code:
NCT03511586
Conditions
Shoulder Arthroplasty
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted